Yourgene up on regulatory nod

By
0 mins. to read
Yourgene up on regulatory nod

AIM-listed molecular diagnostics specialist Yourgene Health (LON:YGEN) has seen its share price climb by 6.51% to 19.97p (as of 15:00 BST) after it received accreditation from the Care Quality Commission for its second facility in Manchester.

The company said that this allowed them greater flexibility to provide both public and private COVID testing in the city.

Take part in our poll

Where do you go for your research?


“Moo’s

Comments (0)

Leave a Reply

Your email address will not be published. Required fields are marked *